Here's what the studies looked at
An honest summary of the published BPC-157 research, what kind of studies exist, and what has not been studied.
You will see confident claims about BPC-157 online. This guide explains what kind of research those claims rest on, so you can judge them yourself.
Most of the research is in rodents
The bulk of published BPC-157 work has been carried out in rats and mice, along with cell studies. A large share comes from one research group in Croatia that has studied the compound for decades.
Animal models are a normal first step in research. They are not proof that something works, or is safe, in another species.
The areas researchers have explored
Published animal studies have looked at models of:
- tendon, ligament and muscle injury
- stomach and gut lining damage
- skin wounds and burns
- blood vessel formation
In these models, researchers reported changes in how tissue responded. The mechanisms are still debated.
What has not been done
- No large controlled trials in dogs. We are not aware of any published, controlled clinical trial of BPC-157 in dogs.
- Very little human data. Human evidence is limited to small, early studies.
- Limited long-term safety data. Short animal studies cannot answer questions about long-term use.
- Limited independent replication. Much of the literature comes from a small number of teams.
How to read the papers yourself
You can search the published literature directly on PubMed: BPC 157 search results. When you open a paper, look for:
- The species studied.
- The number of animals.
- Whether there was a control group.
- Who funded the work.
Why we write it this way
Our promise is clear explanations and honest answers. BPC-157 is an interesting research compound. It is not an authorised veterinary medicine, and we will not describe it as one.
If your dog has a health problem, your vet is the right person to speak to. Questions to ask your vet can help you prepare.